25 May 2013
Keywords: s-p, 4th-qtr, results, hit, organon, buy, drug
Article | 18 February 2008
US drug major Schering-Plough's fourth-quarter 2007 results were hit by costs related to last year's acquisition of Organon BioSciences from
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 February 2008
24 May 2013
© 2013 thepharmaletter.com